Tirzepatide Mechanism of Action: What GIP and GLP-1 Do
A prescription shot called tirzepatide is made from 39-amino-acid parts, the small pieces in protein. This page explains hunger, blood sugar, and what twelve phase-3, or large late, trials found.
How Tirzepatide Changes Hunger and Blood Sugar
Two gut hormones, GIP and GLP-1, enter the blood after a meal. Tirzepatide copies both. When sugar rises in the blood, GIP tells the pancreas to send out insulin. Both slow the stomach and help you feel full [1][19]. Glucagon can drive blood sugar higher, and the drug lowers it.
Tirzepatide copies GIP quite closely. It copies GLP-1 less closely [1]. Even so, cells kept answering the GLP-1 copy for longer [1]. This wasn't found in people. It came from cells kept in a dish. It may help explain why insulin release lasted in the lab [1].
A 2022 study used a strong microscope to see where the GIP and GLP-1 copies touched a cell. One end copied GIP. A fat part changed how the drug touched the cell for GLP-1 [2]. That helps explain why tirzepatide acts like GIP and GLP-1, not just one hormone [2].
How tirzepatide works, in short
Tirzepatide acts like GIP and GLP-1 at once. The cells' reply can affect hunger. The shot can raise insulin when blood sugar rises, lower glucagon, slow the stomach, and help you feel full. It also helped the body use insulin better after researchers set weight loss aside [1][19].
Is tirzepatide only a one-hormone drug?
No. Tirzepatide copies two gut hormones, while some other shots copy only one. Lab work found that it copied the two in different ways [1]. I'd ask what that difference may mean for you, not just what the drug is called.
What Helps Tirzepatide Last Through the Week
Tirzepatide is built from 39-amino-acid parts, the small pieces in protein. Two changes made in the lab help the drug avoid being broken down too soon [1]. A small fat part lets it hold onto albumin, one of the blood's proteins. More than 99% travels that way. This helps explain why the shot lasts near five days and was used weekly [3].
The fat part does two things. It slows how fast the body clears the drug. It also changes how a cell answers one gut hormone [2]. In cells in a dish, that reply lasted longer before the cell pulled the drug inside [1][2].
Tirzepatide Half-Life: Why the Shot Lasts for Days
Researchers tracked tirzepatide in phase 2 and 3 trials, the middle and large late tests [3]. About half of one shot remained in the body after five days. That is why the studies used it weekly. About 80% reached the blood after a shot. The body broke down or cleared the rest. Blood levels were highest 8 to 72 hours later. After about four weeks of weekly use, the amount going in matched the amount leaving [3].
The study found no need to change the amount just because of age, sex, race, or body size [3]. More than 99% rode through the blood on the blood protein albumin. The body broke tirzepatide into small protein parts, then passed them in urine and stool [3].
How Long Does Tirzepatide Stay in Your System?
On average, about half of tirzepatide remained in the body after five days. After about four weeks of weekly use, blood levels stopped building from week to week [3]. That timing matched the four-week steps in SURPASS and SURMOUNT.
What Does Tirzepatide Do to Your Body?
In the studies, tirzepatide lowered blood sugar before and after meals. It raised insulin, lowered glucagon, slowed the stomach, eased hunger, and cut deep belly fat. In SURPASS-2, the insulin-making cells worked better. The body also used insulin better [10][12]. Those tests don't predict your own result.
What Weekly Tirzepatide Changed for Diabetes
Six phase-3 SURPASS trials, the large late tests, studied adults with type 2 diabetes. SURPASS-1 tested tirzepatide without another diabetes drug. The studies compared weekly tirzepatide at 5, 10, and 15 mg with a placebo, three types of insulin, and two other weekly diabetes shots. Those two shots were semaglutide 1 mg and dulaglutide [4][5][6].
SURPASS-1 was a 40-week study using tirzepatide alone. The blood test showing average sugar over several months fell 1.87, 1.89, and 2.07 points at 5, 10, and 15 mg. Placebo rose +0.04%. Weight fell 7.0, 7.8, and 9.5 kg. A blood-test result of 6.5% or less was reached by 81–86%, compared with 10% on placebo [4].
SURPASS-2 was a 40-week study with 1,879 people. The same blood test fell 2.01, 2.24, and 2.30 points with tirzepatide, compared with 1.86 on semaglutide 1 mg. Weight fell 7.6, 9.3, and 11.2 kg, compared with 5.7 kg. Tirzepatide did better on blood sugar at all three amounts. It did better on weight at 10 and 15 mg [5].
SURPASS-1 to -5 together included 6,263 people taking tirzepatide. The study asked who reached three goals. They were an average-sugar result below 7.0%, at least 5% weight loss, and no very low blood sugar. Tirzepatide reached all three in 43% to 82%, compared with 4–5% on placebo [6].
SURPASS-3 and SURPASS-4 compared tirzepatide with long-lasting insulin. Tirzepatide did better for the long-term blood-sugar test and for weight [6].
How much did weekly tirzepatide help diabetes?
Across SURPASS-1 through -5, the long-term blood-sugar test fell 1.87 to 2.59 points over the 5–15 mg range. Among 6,263 people, 43–82% got below 7%, lost at least 5%, and avoided very low blood sugar [6].
What happened after long-term tirzepatide use?
In the 72-week SURMOUNT-1 study, weight was still falling at 15 mg. In SURMOUNT-4, people stopped after 36 weeks, when average loss was −20.9%. They regained 14.0% over 52 weeks. Those who stayed on tirzepatide lost another 5.5%. Among those who stopped, 16.6% kept at least 80% of the loss. Among those who stayed on it, 89.5% kept that much [9]. The study can't tell your own future.
For your next visit, you won't need to recite every blood-test number, and you don't have to choose care before your questions are answered. Ask which sugar change matters for you, what won't apply to your health, what isn't clear from these group results, and what can't be known from one study alone. I'd start with who will check your blood sugar, because you can't tell from the study how often your own visits may be. Your cost isn't in these results, and the study can't tell you whether your plan will pay and doesn't know what you can pay. A group result won't name your outcome, so it shouldn't stand in for your doctor's view of you.
Tirzepatide vs Semaglutide: What One Study Found
SURPASS-2 is the only finished phase-3 trial, one of the final large tests, that compared the two drugs directly. It followed 1,879 adults with type 2 diabetes for 40 weeks [5]. They took tirzepatide at 5, 10, or 15 mg, or semaglutide 1 mg each week. Semaglutide is a diabetes shot taken once a week. The long-term blood-sugar test fell more with every tirzepatide amount. The gaps were −0.15, −0.39, and −0.45 points. Weight fell more at 10 and 15 mg, by gaps of −3.6 and −5.5 kg. Stomach and bowel side effects were much the same with semaglutide 1 mg [5].
A second look at SURPASS-2 used two lab tests. With tirzepatide, the insulin-making cells improved 96.9–120.4%, compared with 84.0% on semaglutide. The body also used insulin 15.5–24.0% better, compared with 5.1% on semaglutide [10]. Researchers tied part of that gain to the second gut hormone copied by tirzepatide [10].
Here's the limit. SURPASS-2 used semaglutide 1 mg, not the 2.4 mg amount studied for obesity. No finished phase-3 study had compared tirzepatide with semaglutide 2.4 mg for weight by 2025. The main heart study compared tirzepatide with dulaglutide, a once-a-week diabetes shot [14].
Is tirzepatide better than semaglutide?
SURPASS-2 tested tirzepatide (5/10/15 mg) against semaglutide 1 mg. Tirzepatide lowered the long-term blood-sugar test more at every amount. Weight fell more at 10 and 15 mg. Two tests of insulin use also favored tirzepatide [5][10]. A phase-3 weight study against semaglutide 2.4 mg wasn't yet finished.
What differs between tirzepatide and semaglutide?
Semaglutide copies the gut hormone GLP-1. Tirzepatide copies GLP-1 plus another hormone from the gut. The second may work alongside GLP-1 to help your body use insulin and burn stored fat [1][10][19]. That difference can't make the drug choice for you.
What tirzepatide changed in sleep apnea
SURMOUNT-OSA (2024) studied adults with worse sleep apnea and obesity. Two large trials included people with and without a breathing mask. Breathing pauses fell about 25 events/hour without the mask and 29 events/hour with it. Placebo groups improved 5–6 events/hour over 52 weeks [13]. Most of the change came with weight and deep belly-fat loss, not a direct airway change. Time spent short of oxygen also fell. So did a blood sign of body-wide swelling and the top blood-pressure number [13].
When you compare the two shots, you don't have to treat one study as the last word, and it can't account for every part of your health or needs. Ask which amount was tested, which side effects won't suit you, whether the study looked at your goal, and what it can't answer. I'd also ask how long your clinic wants to watch you, because that time isn't shown by the headline result. A study result can't stand in for your cost, and the paper can't show what your plan covers or what it doesn't cover. One direct trial helps, but it doesn't settle your choice or replace your doctor's knowledge of you.